Latest Articles

Publication Date
Amy Schumer's health struggles from endometriosis and Lyme disease to chronic pain - after she sparked concern - Daily Mail

Amy Schumer's health struggles from endometriosis and Lyme disease to chronic pain - after she sparked concern Daily Mail

Published: Feb. 16, 2024, 8 a.m.
Five grants awarded for research on lifestyle interventions in healthcare - Impact of lifestyle interventions on Parkinson's disease, endometriosis, depression, dementia, and gastric bypass surgery - Radboudumc

Five grants awarded for research on lifestyle interventions in healthcare - Impact of lifestyle interventions on Parkinson's disease, endometriosis, depression, dementia, and gastric bypass surgery Radboudumc

Published: Feb. 13, 2024, 9:18 a.m.
Many with Meniere's disease based on ICD-10 do not meet AAO-HNS criteria - Medical Xpress

Many with Meniere's disease based on ICD-10 do not meet AAO-HNS criteria Medical Xpress

Published: Feb. 2, 2024, 8 a.m.
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway | Cell Death & Disease - Nature.com

The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway | Cell Death & Disease Nature.com

Published: Jan. 18, 2024, 8 a.m.
Call for lipid disorder action plan amid increase in heart disease - MJA Insight

Call for lipid disorder action plan amid increase in heart disease MJA Insight

Published: Jan. 15, 2024, 8 a.m.
Hulda Clark’s “zapper” device is based on pseudoscience; doesn’t kill parasites or cure diseases - Science Feedback

Hulda Clark’s “zapper” device is based on pseudoscience; doesn’t kill parasites or cure diseases Science Feedback

Published: Jan. 12, 2024, 8 a.m.
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million - Business Wire

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million Business Wire

Published: Jan. 8, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!